“…In humans, the 5% IMQ cream formulation Aldara® is frequently used for the treatment of genital warts, actinic keratosis and superficial basal cell carcinomas with very high response rates (Bath-Hextall et al, 2014;de Macedo et al, 2015;Gollnick et al, 2005;Peris et al, 2014). In mice and humans topical application of IMQ results in the activation of the interfollicular epidermis (IFE), upregulation of MHC-II on keratinocytes, hyperproliferation and parakeratosis (Flutter and Nestle, 2013), as well as a strong skin inflammation characterized by the infiltration of several immune cells such as plasmacytoid dendritic cells (Drobits et al, 2012;Kalb et al, 2012;Palamara et al, 2004), mast cells (Heib et al 2007), monocytes (Terhorst et al, 2015) and T cells and activation of the IL23/IL17/IL22 axis (Heib et al, 2007;Riol-Blanco et al, 2014;van der Fits et al, 2009).…”